Skip to content

Home
Our research
Market
Plans
Partnering
About us

Menu

Home
Our research
Market
Plans
Partnering
About us

Bokslutskommuniké för 2015 publicerad

Bokslutskommuniké för perioden 2015-01-01 till 2015-12-31 är nu publicerad.

Contact us

Tore Duvold

Twitter Linkedin Facebook Youtube

As part of Coegin Pharma AB’s hub & spoke “portfolio” business model, with clear benefits to investors, Coegin Pharma AB has established the Swedish portfolio company Follicum AB to further develop a highly promising dermacosmetic product line based on FOL005 to stimulate hair growth. Follicum AB will primarily be managed and financed separately from Coegin Pharma AB.

© All Rights Reserved